SCHEMBL13617385

SCHEMBL13617385

CCc1cc(CO)ccc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 2/20 0.51
CYP4A11 Q02928 2/20 0.51
BACE1 P56817 1/20 0.43
KIF11 P52732 1/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
HSD17B10 Q99714 1/20 0.37
GAA P10253 1/20 0.36
SLC9A1 P19634 1/20 0.36
EGFR P00533 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
CASP6 P55212 1/20 0.35
RIPK1 Q13546 2/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8205755 0.85 TRPA1 (0.43) BACE1KDM4EMAPTLMNATP53
SCHEMBL28182676 0.85 CYP4F2 (0.47) CYP4F2CYP4A11KIF11KDM4EMAPT
SCHEMBL14491132 0.83 CYP4F2 (0.47) CYP4F2CYP4A11BACE1KIF11KDM4E
SCHEMBL8773286 0.83 TRPA1 (0.43) CYP4F2CYP4A11BACE1KIF11LMNA
SCHEMBL14402511 0.81 BACE1 (0.40) CYP4F2CYP4A11BACE1KDM4EMAPT
SCHEMBL606892 0.80 EGFR (0.43) CYP4F2CYP4A11BACE1KDM4EMAPT
SCHEMBL3690355 0.79 BACE1 (0.47) BACE1GAASLC9A1MAOB
SCHEMBL2386178 0.79 CYP4F2 (0.43) CYP4F2CYP4A11BACE1KIF11MAOB
SCHEMBL8055086 0.79 BACE1 (0.39) CYP4F2CYP4A11BACE1KDM4EMAPT
SCHEMBL17508770 0.79 CYP4F2 (0.43) CYP4F2CYP4A11KIF11KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10736904-B2 Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof SANOFI (FR) 2020-08-11 US disclosed
EP-2900645-A1 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION Bayer CropScience AG (DE) 2015-08-05 EP disclosed
WO-2009133831-A1 PHENYLPROPIONIC ACID DERIVATIVE AND USE THEREOF 旭化成ファーマ株式会社 (JP) 2009-11-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10736904-B2 Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof DPYD, TYMP, DHFR CYP4F2 23/4885CYP4A11 192/4885BACE1 2419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.